FDA Inspection
Dexcel Pharma Ltd.Dexcel Pharma Ltd. – FDA Inspection, Feb 16, 2017
Record Details
This FDA Inspection record concerns Dexcel Pharma Ltd., with an inspection on February 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · cfef2ab3-f0eb-4b7b-bb92-e3ec84498568
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1007877
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Dexcel Pharma Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 14, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 5, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dexcel Pharma Ltd.
- FDA Inspection 1195631 - 2022-12-14
- FDA Inspection 1097285 - 2019-07-24
- FDA Inspection 836838 - 2013-06-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.